Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
| Revenue (Most Recent Fiscal Year) | $10.27B |
| Net Income (Most Recent Fiscal Year) | $157.00M |
| PE Ratio (Current Year Earnings Estimate) | 1.33 |
| PE Ratio (Trailing 12 Months) | 1.36 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.20 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 0.80 |
| Pre-Tax Margin (Trailing 12 Months) | -6.74% |
| Net Margin (Trailing 12 Months) | -10.12% |
| Return on Equity (Trailing 12 Months) | -561.95% |
| Return on Assets (Trailing 12 Months) | 6.31% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.44 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.08 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
| Inventory Turnover (Trailing 12 Months) | 1.90 |
| Book Value per Share (Most Recent Fiscal Quarter) | $1.02 |
| Earnings per Share (Most Recent Fiscal Quarter) | $1.26 |
| Earnings per Share (Most Recent Fiscal Year) | $3.73 |
| Diluted Earnings per Share (Trailing 12 Months) | $-2.96 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Common Shares Outstanding | 374.14M |
| Free Float | 296.81M |
| Market Capitalization | $2.17B |
| Average Volume (Last 20 Days) | 1.82M |
| Beta (Past 60 Months) | 0.37 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 20.67% |
| Percentage Held By Institutions (Latest 13F Reports) | 78.65% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |